Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936845 · ClinicalTrials.gov registry record
Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 22
- Enrollment target
NCT00936845: Completed study, sponsored by Weill Medical College of Cornell University.
NCT00936845 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00936845 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
To collect and analyze data on females with hemophilia so as to better define the difference between the study population and the male population with hemophilia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2005-04 |
| Est. Completion | 2010-01 |
What the finished NCT00936845 record still lists
NCT00936845 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00936845 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00936845 about?
NCT00936845 is a clinical study titled "Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study". To collect and analyze data on females with hemophilia so as to better define the difference between the study population and the male population with hemophilia.
What is the current status of trial NCT00936845?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2005-04. Estimated completion is 2010-01.
Who is sponsoring clinical trial NCT00936845?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia